CASI Pharmaceuticals, Inc. - CASI

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 25
Latest filed: Mar 23, 2026
Form Count
6-K 13
SCHEDULE 13D/A 8
SCHEDULE 13G/A 3
SCHEDULE 13G 1

Latest files

Filed Form Report period Accession SEC
Mar 23, 2026 SCHEDULE 13D/A 0001104659-26-032956 View
Mar 03, 2026 6-K Mar 03, 2026 0001104659-26-022579 View
Feb 25, 2026 6-K Feb 25, 2026 0001104659-26-019440 View
Feb 20, 2026 6-K Feb 20, 2026 0001104659-26-017895 View
Feb 19, 2026 6-K Feb 19, 2026 0001104659-26-017304 View
Feb 17, 2026 SCHEDULE 13G/A 0001738048-26-000016 View
Feb 13, 2026 SCHEDULE 13G/A 0001104659-26-015415 View
Feb 10, 2026 SCHEDULE 13D/A 0001104659-26-012278 View
Feb 10, 2026 6-K Feb 10, 2026 0001104659-26-012391 View
Jan 29, 2026 SCHEDULE 13D/A 0001104659-26-008171 View
Jan 22, 2026 6-K Jan 22, 2026 0001104659-26-005647 View
Jan 20, 2026 SCHEDULE 13D/A 0000929638-26-000184 View
Jan 20, 2026 SCHEDULE 13D/A 0000929638-26-000185 View
Jan 13, 2026 6-K Jan 13, 2026 0001104659-26-003118 View
Jan 09, 2026 SCHEDULE 13D/A 0001104659-26-002272 View
Dec 31, 2025 6-K Dec 30, 2025 0001104659-25-125300 View
Dec 23, 2025 6-K Dec 23, 2025 0001104659-25-124228 View
Dec 18, 2025 SCHEDULE 13D/A 0001104659-25-122209 View
Dec 17, 2025 SCHEDULE 13D/A 0001193125-25-322768 View
Dec 11, 2025 6-K Dec 11, 2025 0001104659-25-120162 View
Nov 26, 2025 SCHEDULE 13G 0001104659-25-116430 View
Nov 19, 2025 6-K Nov 19, 2025 0001104659-25-113974 View
Nov 14, 2025 SCHEDULE 13G/A 0001104659-25-112486 View
Nov 14, 2025 6-K Nov 14, 2025 0001104659-25-112605 View
Nov 10, 2025 6-K Nov 10, 2025 0001104659-25-109186 View